Intentional Self-Poisoning With the Chlorophenoxy Herbicide 4-Chloro-2-Methylphenoxyacetic Acid (MCPA) - 18/08/11
, Ruwan Seneviratne, MBBS, Fahim Mohammed, BPharm, Renu Patel, BSc, Lalith Senarathna, BSc, Ariyasena Hittarage, MD, MRCP, Nick A. Buckley, MD, FRACP, Andrew H. Dawson, MBBS, FRACP, Michael EddlestonAbstract |
Study objective |
Data on poisoning with MCPA (4-chloro-2-methyl-phenoxyacetic acid) are limited to 6 case reports. Our objective is to describe outcomes from intentional self-poisoning with MCPA in a prospective case series of 181 patients presenting to hospitals in Sri Lanka.
Methods |
Patient information was collected by on-site study physicians as part of an ongoing prospective cohort study of poisoned patients. Medical history, clinical details, and blood samples were obtained prospectively.
Results |
Overall clinical toxicity was minimal in 85% of patients, including mild gastrointestinal symptoms in 44% of patients. More severe clinical signs of chlorophenoxy poisoning reported previously, such as rhabdomyolysis, renal dysfunction, and coma, also occurred but were uncommon. Eight patients died (4.4%). Most deaths occurred suddenly from cardiorespiratory arrest within 48 hours of poisoning; the pathophysiological mechanism of death was not apparent. The correlation between admission plasma MCPA concentration and clinical markers of severity of toxicity (physical signs, symptoms, and increased creatine kinase level) was poor.
Conclusion |
Intentional self-poisoning with MCPA generally causes mild toxicity, but cardiorespiratory arrest and death may occur. All patients should receive routine resuscitation and supportive care. It seems reasonable to correct acidosis and maintain an adequate urine output, but there is insufficient evidence to support other specific interventions. Our data do not support a clinical role for measurement of plasma MCPA in the acute management of poisoning, and insufficient data were available to fully examine the utility of measured electrolytes and creatine kinase levels.
Le texte complet de cet article est disponible en PDF.Plan
| Supervising editor: Richard C. Dart, MD, PhD Author contributions: NAB and ME designed the randomized controlled trial and obtained research funding. ME established the trial and recruited hospitals. FM, LS, and ME supervised the conduct of the trial, data collection, and data management. DMR coordinated data retrieval with the assistance of RS, FM, and LS. DMR conducted the primary analysis, liaised with the analytical laboratory, reviewed medical charts, performed the literature search, and drafted the manuscript. RP provided advice on laboratory analyses and takes responsibility for these results. AH was responsible for the clinical care of the patients. NAB, AHD, and ME provided statistical advice and assisted with data interpretation. All authors approved the final version. DMR takes responsibility for the paper as a whole. Funding and support: DMR is funded by a scholarship from the National Health and Medical Research Council (Australia). ME is a Wellcome Trust Career Development Fellow, funded by grant GR063560MA from the Wellcome Trust's Tropical Interest Group. The South Asian Clinical Toxicology Research Collaboration is funded by a Wellcome Trust/National Health and Medical Research Council International Collaborative Research Grant GR071669MA. Presented at the CPT2004 (Clinical Pharmacology and Therapeutics 2004) international meeting, August 2004, Brisbane, Australia. Reprints not available from the authors. |
Vol 46 - N° 3
P. 275-284 - septembre 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
